Applied Therapeutics Inc [NASDAQ: APLT] loss -4.67% or -0.29 points to close at $5.92 with a heavy trading volume of 3061333 shares. The company report on April 4, 2024 at 7:00 AM that Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic
Applied Therapeutics Inc [NASDAQ: APLT] stock went on an upward path that rose over 32.62% on Wednesday, amounting to a one-week price increase of more than 44.25%. The company report on February 28, 2024 at 8:05 AM that Applied Therapeutics Announces $100 Million Private Placement.
Applied Therapeutics Inc [NASDAQ: APLT] closed the trading session at $5.38. The company report on February 15, 2024 at 7:00 AM that Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD)
Applied Therapeutics Inc [NASDAQ: APLT] traded at a high on Thursday, posting a 39.93 gain after which it closed the day’ session at $3.75. The company report on February 15, 2024 at 7:00 AM that Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of
© 2024, Powered by Smart TechOne
